Search - tctmd.com

Displaying 101 - 120 of 342

Sort: Relevancy | Date

Presentation TCT 2023

Trialist Perspectives

Presenter: Felix Mahfoud

October 24, 2023

Presentation TCT 2023

A Novel Transfemoral Aortic Valve Replacement System (Hanchor Valve) for Pure Native Aortic Regurgitation (PNAR)

Presenter: Wenzhi Pan

October 24, 2023

Presentation TCT 2023

Implications for RCTs and Work Force Considerations

Presenter: Roxana Mehran

October 24, 2023

Presentation TCT 2023

DurAVR Transcatheter Heart Valve: Early Feasibility Study

Presenter: Azeem Latib

October 24, 2023

Presentation TCT 2023

Robotically Developed Polymeric-Based Leaflet Technology (Foldax): Technology and Clinical Program Update

Presenter: Isaac George

October 24, 2023

Presentation TCT 2023

Comparison of Two Self-Expanding Transcatheter Heart Valves for Degenerated Surgical Bioprostheses: The AVENGER Multi-Center Registry

Presenter: Won-Keun Kim

October 24, 2023

Presentation TCT 2023

FDA DEI Initiatives

Presenter: Jaime Raben

October 24, 2023

Presentation TCT 2023

One-Year Outcomes With Fourth-Generation Mitral Valve Transcatheter Edge-to-Edge Repair From EXPAND G4

Presenter: Ralph Stephan von Bardeleben

October 24, 2023

Presentation TCT 2023

One-Year Outcomes after Amulet or Watchman/FLX Device for Percutaneous Left Atrial Appendage Closure: a Pre-Specified Analysis of the SWISS-APERO Randomized Clinical Trial

Presenter: Roberto Galea

October 24, 2023

Presentation TCT 2023

TRILUMINATE Pivotal: Outcomes of Both Randomized and Single-arm Subjects with Transcatheter Tricuspid Valve Edge-to-Edge Repair for Tricuspid Regurgitation

Presenter: David Adams

October 24, 2023

Presentation TCT 2023

Clinician Perspectives

Presenter: Roxana Mehran

October 24, 2023

Presentation TCT 2023

Industry Perspectives

Presenter: Duane Pinto

October 24, 2023

Presentation TCT 2023

Tendyne SUMMIT Pivotal Trial Roll-In and MAC Arm Outcomes

Presenter: Jason Rogers

October 24, 2023

Presentation TCT 2023

FDA Perspectives

Presenter: Katherine Trivedi

October 24, 2023

Presentation TCT 2023

Five-year Echocardiographic Outcomes From The PARTNER 3 Low-risk Randomized Trial

Presenter: Rebecca Hahn

October 24, 2023

Presentation TCT 2023

Overcoming the "Credibility Crisis" of Observational Data

Presenter: Robert Yeh

October 24, 2023

Presentation TCT 2023

Discussion and Closing Remarks

Presenter: Robert Yeh

October 24, 2023

Presentation TCT 2023

Lithotrispy: A novel approach to calcium fragmentation

Presenter: Stefan Verheye

October 24, 2023

Presentation TCT 2023

Technology options for patients at high thrombotic risk: Why care?

Presenter: Roxana Mehran

October 24, 2023

Presentation TCT 2023

What is the long-term potential for restoring vessel function

Presenter: IGNACIO CRUZ GONZALEZ

October 24, 2023

Advertisement

Trialist Perspectives

A Novel Transfemoral Aortic Valve Replacement System (Hanchor Valve) for Pure Native Aortic Regurgitation (PNAR)

Implications for RCTs and Work Force Considerations

DurAVR Transcatheter Heart Valve: Early Feasibility Study

Robotically Developed Polymeric-Based Leaflet Technology (Foldax): Technology and Clinical Program Update

Comparison of Two Self-Expanding Transcatheter Heart Valves for Degenerated Surgical Bioprostheses: The AVENGER Multi-Center Registry

FDA DEI Initiatives

One-Year Outcomes With Fourth-Generation Mitral Valve Transcatheter Edge-to-Edge Repair From EXPAND G4

One-Year Outcomes after Amulet or Watchman/FLX Device for Percutaneous Left Atrial Appendage Closure: a Pre-Specified Analysis of the SWISS-APERO Randomized Clinical Trial

TRILUMINATE Pivotal: Outcomes of Both Randomized and Single-arm Subjects with Transcatheter Tricuspid Valve Edge-to-Edge Repair for Tricuspid Regurgitation

Clinician Perspectives

Industry Perspectives

Tendyne SUMMIT Pivotal Trial Roll-In and MAC Arm Outcomes

FDA Perspectives

Five-year Echocardiographic Outcomes From The PARTNER 3 Low-risk Randomized Trial

Overcoming the "Credibility Crisis" of Observational Data

Discussion and Closing Remarks

Lithotrispy: A novel approach to calcium fragmentation

Technology options for patients at high thrombotic risk: Why care?

What is the long-term potential for restoring vessel function

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content